logo
Select company
Select metric
$ 320KDepreciation, Amortization & Accretion
VS
Market
12
Sector
24
Industry
33
History
-
$ 5.93Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information

Ticker

KPTI

Company Name

KARYOPHARM THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KARYOPHARM THERAPEUTICS INC - Depreciation, Amortization & Accretion Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KPTI - DepAmor Historical data
DateDepreciation, Amortization & Accretion
6/30/2025$ 320K
3/31/2025$ 333K
12/31/2024$ 340K
9/30/2024$ 336K
6/30/2024$ 333K
3/31/2024$ 325K
12/31/2023$ 530K
9/30/2023$ 566K
6/30/2023$ 668K
3/31/2023$ 734K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor stands at $ 959K.
  • Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average DepAmor has been $ 634.15K.
  • The median DepAmor for KARYOPHARM THERAPEUTICS INC during this period was $ 649K
  • KARYOPHARM THERAPEUTICS INC reached its highest DepAmor over the past 5 years at $ 972K.
  • The lowest DepAmor recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe $ 320K

KARYOPHARM THERAPEUTICS INC's DepAmor vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

DepAmor Benchmarks
CompanyDepAmor
IPSC : CENTURY THERAPEUTICS INC $ 14.14MMRSN : MERSANA THERAPEUTICS INC $ 4.69MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ 10.63MIGC : IGC PHARMA INC $ 597KXLO : XILIO THERAPEUTICS INC $ 1.63MALXO : ALX ONCOLOGY HOLDINGS INC $ 840KGBIO : GENERATION BIO CO $ 4.63MCLSD : CLEARSIDE BIOMEDICAL INC $ 323KTAOX : TAO SYNERGIES INC $ 4.88KESLA : ESTRELLA IMMUNOPHARMA INC $ 0

Definition of Depreciation, Amortization & Accretion

[Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.

KPTI - Depreciation, Amortization & Accretion, Last 5 years

$ 320K

Minimum

Jun 30, 2025

$ 972K

Maximum

Dec 31, 2020

$ 634.15K

Average

$ 649K

Median

DepAmor Benchmark Analysis

The chart above depicts the distribution of DepAmor for companies in the Total Stock Market. The average DepAmor of the companies is $ 24.06M with a standard deviation of $ 33.58M.
The following table provides additional summary stats:
DepAmor in the Market:
filtered constituents3.16K
min$ -81M
max$ 135.97M
average$ 24.06M
median$ 6.83M
std$ 33.58M